WHO GMP gap identified during internal gap assessment – avoiding repeat WHO observations



Published on 28/01/2026

Addressing Identified WHO GMP Gaps from Internal Assessments

Pharmaceutical professionals know that maintaining compliance with WHO Good Manufacturing Practices (GMP) is not just about adhering to regulatory expectations; it also involves continuous improvement to avoid repeat observations during inspections. Utilizing internal gap assessments effectively can identify weaknesses in systems and processes, mitigating the risk of compliance failures. This article serves as a practical playbook, guiding you through quick triage, deep-dive analysis, corrective actions, and effective documentation strategies.

After reading this article, readers will be equipped to conduct thorough internal evaluations, address WHO GMP gaps effectively, and maintain an inspection-ready stance. The actionable steps outlined herein will enhance Quality Management Systems (QMS) and prepare your organization for upcoming inspections while minimizing the risk of negative outcomes.

Symptoms/Signals on the Floor or in the Lab

Identifying gaps in WHO GMP compliance starts with observing key symptoms in production, quality control, and laboratory environments. Symptoms that typically

signify potential compliance issues include:

  • Increased Deviations: Frequent nonconformance reports or deviations from documented processes could signal systemic issues.
  • Quality Complaints: A spike in batch failures or product quality complaints from clients often indicates underlying procedural failures.
  • Audit Findings: Negative outcomes or observations in internal or external audits provide tangible evidence of compliance gaps.
  • Training Deficiencies: Identify if employees are struggling with SOPs, reflecting inconsistencies in training and knowledge.
  • Equipment Malfunctions: Frequent breakdowns or failures of critical manufacturing equipment may reveal inadequacies in maintenance protocols.

Each of these symptoms can lead to troubling compliance gaps if not addressed promptly. They should be recorded and analyzed to determine the direction of further investigation.

Likely Causes

Understanding the roots of identified symptoms is crucial. Causes can generally be categorized into several areas:

Category Likely Causes
Materials Substandard raw materials or inadequate supplier controls.
Method Outdated methods or deviations from SOPs during execution.
Machine Equipment not validated or poorly maintained; calibration lapses.
Man Insufficient training or lack of personnel engagement and accountability.
Measurement Inaccurate testing due to instrument failure or inadequate procedures.
Environment Breakdowns in facility controls for cleanliness or environmental conditions.
Pharma Tip:  Documentation not aligned to WHO during prequalification preparation – gap remediation roadmap

Immediate Containment Actions (first 60 minutes)

Upon identification of symptoms indicating a WHO GMP gap, immediate containment actions should be implemented. This first response should focus on limiting further impact:

  1. Stop Production: Temporarily halt processes if a significant compliance issue is identified to prevent further risk to product quality.
  2. Notify Stakeholders: Inform key team members including Production, QA, and management about the situation for alignment on response strategy.
  3. Isolate Non-compliant Components: Identify and quarantine affected batches or materials, preventing their release or further processing.
  4. Document Findings: Ensure all actions taken are recorded immediately in the appropriate logs to facilitate follow-up investigations.
  5. Engage Relevant Teams: Involve cross-functional teams (QA, Engineering, etc.) to formulate a plan for investigation and resolution.

Investigation Workflow

Conducting a thorough investigation is crucial for determining the roots of identified gaps or symptoms. Here are key steps within an effective investigation workflow:

  1. Data Collection: Gather relevant data: batch records, deviation reports, environmental monitoring results, employee training records, and equipment maintenance logs.
  2. Data Analysis: Evaluate collected data for consistency and trends, considering both quantitative and qualitative information.
  3. Team Collaboration: Engage cross-functional members for diverse perspectives, ensuring comprehensive understanding and analysis.
  4. Documentation: Maintain accurate accounts of findings, which will be critical for root cause analysis and subsequent reporting.

Successful investigations ultimately hinge on structured data collection and collaborative analysis to uncover underlying issues while promoting an environment of continuous improvement.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Determining the root cause of compliance gaps often requires structured analytical tools. Here are three valuable methodologies, their applications, and when to employ each:

5-Why Analysis

This technique involves asking “why” multiple times (usually five) until the fundamental cause is uncovered. It is effective for straightforward issues where the root cause is not immediately apparent and allows teams to dig into each preceding level of the issue.

Fishbone Diagram (Ishikawa)

The Fishbone diagram organizes potential causes into categories, such as the 6 Ms (Man, Machine, Method, Material, Measurement, Environment). This method is particularly useful for complex issues with multiple contributing factors, providing a visual way to analyze diverse causes in relation to a particular problem.

Fault Tree Analysis

This deductive analysis is useful for identifying different pathways leading to a failure, which can be particularly relevant for technical or engineering-related problems. It helps in systematically breaking down how failures can occur, but may require more extensive resources and expertise.

CAPA Strategy (Correction, Corrective Action, Preventive Action)

Implementing an effective Corrective and Preventive Action (CAPA) strategy is integral to addressing identified gaps. A complete CAPA strategy should encompass the following:

  1. Correction: Actions taken to rectify the immediate nonconformance. For instance, release or re-test affected batches.
  2. Corrective Action: Focused actions to eliminate the underlying causes of identified problems. For example, revising troublesome SOPs or providing additional training to staff.
  3. Preventive Action: Proactive measures integrated into processes to mitigate recurrence. This could include enhanced monitoring techniques, equipment upgrades, or more robust supplier qualifications.
Pharma Tip:  API site WHO GMP risk during WHO inspection – avoiding repeat WHO observations

Establishing a formal CAPA system will ensure documented accountability and facilitate continual improvements in the QMS, reducing the risks of future noncompliance.

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

With gaps identified and addressed, reinforcing controls is critical to sustaining GMP compliance. Various methodologies should be employed in your Control Strategy:

Related Reads

  • Statistical Process Control (SPC): Employ SPC techniques to monitor and control manufacturing processes, utilizing data to detect trends or deviations in real-time.
  • Sampling Plans: Define and enforce robust sampling plans for raw materials and intermediates to detect non-compliances early in the process.
  • Alarms and Alerts: Implement automated alerts for environmental, operational, or equipment parameters that fall out of approved limits to trigger timely interventions.
  • Verification Procedures: Regularly verify equipment calibration, process parameters, and results against set benchmarks to ensure compliance is consistently met.

Continual monitoring utilizing these strategies will help to sustain compliance and proactively identify areas that require further improvement.

Validation / Re-qualification / Change Control Impact (When Needed)

Any changes to processes, equipment, or facilities that arise from corrective actions must be evaluated for validation or re-qualification requirements. Each component should be assessed to confirm:

  • Validation: Are current validation documents inclusive of the newly implemented processes or technologies?
  • Change Control: Ensure significant changes follow a formal change control process to adequately assess impacts on product quality and compliance.
  • Re-qualification: If the parameters of a validated process change, re-qualification may be necessary to maintain compliance with WHO GMP standards.

Effective management of validation and changes not only preserves compliance but fosters an adaptable QMS capable of evolving with industry best practices.

Inspection Readiness: What Evidence to Show (Records, Logs, Batch Docs, Deviations)

Maintaining inspection readiness involves consistent organizational practices that ensure all records are thorough and retrievable:

  • Batch Production Records: Ensure every batch has complete documentation that tracks its production pathway, including raw material sourcing and processing conditions.
  • Deviation Logs: Keep a clear, comprehensive log of all deviations including the context, investigation outcomes, and CAPA actions taken.
  • Training Logs: Document ongoing training and competencies of employees in their respective roles within the QMS.
  • Environmental Monitoring: Maintain thorough documentation of environmental controls to showcase compliance with specified limits.
Pharma Tip:  Documentation not aligned to WHO during WHO inspection – CAPA aligned to WHO standards

Having organized and accessible documentation is vital, as it reflects the company’s commitment to quality and regulatory adherence when auditors from authorities such as the FDA, EMA, or MHRA come to evaluate processes.

FAQs

What is a WHO GMP gap assessment?

A WHO GMP gap assessment identifies shortcomings in compliance with the World Health Organization’s Good Manufacturing Practices standards, focusing on internal processes, systems, and documentation.

Why is it important to address GMP gaps immediately?

Immediate action helps prevent quality failures, regulatory non-compliance, and potential harm to patients, thus safeguarding the organization’s reputation and operational integrity.

What role does CAPA play in addressing GMP gaps?

CAPA is a systematic approach to identifying, investigating, and resolving compliance issues, ensuring not only corrections are made, but underlying problems are addressed to prevent recurrence.

How often should internal gap assessments be conducted?

Regular assessments should be part of an organization’s continuous improvement plan, ideally at least annually, or any time significant changes occur within the manufacturing process.

What are the key signs of a potential GMP compliance issue?

Increased deviations, frequent quality complaints, audit findings, employee training deficiencies, and equipment malfunctions are all significant indicators.

How can SPC help in maintaining GMP compliance?

Statistical Process Control (SPC) helps in monitoring production processes, enabling real-time detection of variations and potential issues, thereby facilitating timely corrective actions.

What is the significance of validation in the context of GMP compliance?

Validation ensures that all processes meet specified standards and that changes do not adversely impact product quality or safety.

Who is responsible for GMP compliance in a pharmaceutical organization?

While overall accountability typically lies with the Quality Assurance department, every employee plays a role in maintaining GMP compliance through their specific processes and practices.

What documentation is essential for inspection readiness?

Critical documentation includes batch records, deviation logs, training records, and environmental monitoring results, all of which demonstrate compliance in practice.

When should a change control process be initiated?

A change control process should be initiated anytime a change may affect product quality, compliance, or safety, ensuring thorough assessment and documentation of those changes.